Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Volume 71, Issue 3
Displaying 1-10 of 10 articles from this issue
Review
  • Takahiro Mori
    2023 Volume 71 Issue 3 Pages 188-197
    Published: March 01, 2023
    Released on J-STAGE: March 01, 2023
    JOURNAL FREE ACCESS FULL-TEXT HTML
Regular Articles
  • Jun Kawahara, Miyako Yoshida, Honami Kojima, Rio Uno, Minoru Ozeki, Ik ...
    2023 Volume 71 Issue 3 Pages 198-205
    Published: March 01, 2023
    Released on J-STAGE: March 01, 2023
    JOURNAL FREE ACCESS FULL-TEXT HTML
  • Liang Xing, Guoliang Gong, Xinyang Chen, Xin Chen
    2023 Volume 71 Issue 3 Pages 206-212
    Published: March 01, 2023
    Released on J-STAGE: March 01, 2023
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Supplementary material
  • Asami Ono, Rena Kurihara, Katsuhide Terada, Kiyohiko Sugano
    2023 Volume 71 Issue 3 Pages 213-219
    Published: March 01, 2023
    Released on J-STAGE: March 01, 2023
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Editor's pick

    The biowaiver scheme based on the biopharmaceutics classification system (BCS-BWS) is used not only as terms of regulatory submissions but also as an indicator for formulation development in drug discovery. The authors investigated the in vitro dissolution rates of formulations of a BCS class III drug and compared them with the criterion in the BCS-BWS. They also discussed the impact of dissolution rates on bioequivalence for BCS class III drugs by virtual simulation. These findings contribute to a better understanding of the biowaiver approach and would help researchers in the formulation development of BCS class III drugs.

  • Tian Li, Yuxiao Hu, Baojun Shi, Wenjun Wu
    2023 Volume 71 Issue 3 Pages 220-228
    Published: March 01, 2023
    Released on J-STAGE: March 01, 2023
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Supplementary material
  • Shinya Kimura, Tomoki Komiyama, Tatsuki Masuzawa, Masashi Yokoya, Taka ...
    2023 Volume 71 Issue 3 Pages 229-233
    Published: March 01, 2023
    Released on J-STAGE: March 01, 2023
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Supplementary material
  • Hiroyuki Watanabe, Takuji Ide, Masahiro Ono
    2023 Volume 71 Issue 3 Pages 234-239
    Published: March 01, 2023
    Released on J-STAGE: March 01, 2023
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Editor's pick

    The orexin 2 receptor plays a critical role in the arousal-promoting function. In vivo imaging of orexin 2 receptor is expected to contribute to elucidation of orexin systems and the development of drugs to treat sleep disorder. The authors newly developed a radioiodinated triazole-pyrolidine derivative to detect orexin 2 receptor in the brain. The authors described that an additional structure-activity relationship study based on the triazole-pyrolidine scaffold to improve brain pharmacokinetics may lead to the development of useful orexin 2 receptor imaging probes.

  • Yoshiaki Kitamura, Mahmoud Kandeel, Erina Oba, Chiori Iwai, Keitaro Ir ...
    2023 Volume 71 Issue 3 Pages 240-249
    Published: March 01, 2023
    Released on J-STAGE: March 01, 2023
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Supplementary material
  • Makoto Oba, Mika Shibuya, Yuto Yamaberi, Hidetomo Yokoo, Satoshi Uchid ...
    2023 Volume 71 Issue 3 Pages 250-256
    Published: March 01, 2023
    Released on J-STAGE: March 01, 2023
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Supplementary material
    Editor's pick

    Cell-penetrating peptides (CPPs) are promising intracellular delivery tools for membrane-impermeable compounds such as small interfering RNAs (siRNAs). In this study, the authors designed amphipathic CPPs containing unnatural amino acids dipropylglycine (Dpg) and explored the cellular uptake and cytotoxicity of peptide/siRNA complexes. The results suggested that the amphipathic structure of peptides played a key role in complexation with siRNAs and intracellular siRNA delivery. A Dpg-containing peptide formed an amphipathic a-helical structure and achieved effective intracellular delivery using small amounts of peptides with negligible cytotoxicity. These findings could be valuable for the design of novel CPPs for siRNA delivery.

Note
  • Yuta Hatanaka, Hiromasa Uchiyama, Shingo Furukawa, Mai Takase, Shinya ...
    2023 Volume 71 Issue 3 Pages 257-261
    Published: March 01, 2023
    Released on J-STAGE: March 01, 2023
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Supplementary material
feedback
Top